购物车
- 全部删除
- 您的购物车当前为空
Gedivumab (MHAA4549A; RG7745),一种高特异性人源单克隆抗体,靶向甲型流感病毒 (IAV),通过与IAV血凝素蛋白的高度保守茎区结合,阻止其成熟并阻断核内体中的血凝素介导的膜融合,适用于IAV感染疾病研究。
Gedivumab (MHAA4549A; RG7745),一种高特异性人源单克隆抗体,靶向甲型流感病毒 (IAV),通过与IAV血凝素蛋白的高度保守茎区结合,阻止其成熟并阻断核内体中的血凝素介导的膜融合,适用于IAV感染疾病研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 询价 | 期货 |
产品描述 | Gedivumab (MHAA4549A; RG7745), a human monoclonal antibody, exhibits high specificity in targeting the influenza A virus (IAV) by binding to the highly conserved stem region of the IAV hemagglutinin protein. This interaction inhibits hemagglutinin maturation and blocks hemagglutinin-mediated membrane fusion within the intranucleosome, making Gedivumab useful for studies on IAV infection disease [1]. |
CAS No. | 1807954-17-1 |
存储 | Shipping with blue ice. |
评论内容